CRESTOR for Coronary artery disease: Side Effects & Safety Data
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
There are 9 adverse event reports in the FDA FAERS database where CRESTOR was used for Coronary artery disease.
Most Reported Side Effects for CRESTOR
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Type 2 diabetes mellitus | 342 | 28.2% | 1 | 4 |
| Cardiovascular disorder | 319 | 26.3% | 0 | 1 |
| Myocardial infarction | 135 | 11.1% | 27 | 43 |
| Myalgia | 87 | 7.2% | 0 | 11 |
| Drug dose omission | 83 | 6.8% | 0 | 29 |
| Blood cholesterol increased | 75 | 6.2% | 0 | 27 |
| Off label use | 60 | 5.0% | 2 | 25 |
| Drug hypersensitivity | 51 | 4.2% | 0 | 5 |
| Intentional product misuse | 49 | 4.0% | 2 | 13 |
| Drug ineffective | 48 | 4.0% | 1 | 17 |
| Malaise | 48 | 4.0% | 3 | 20 |
| Pain | 43 | 3.5% | 0 | 9 |
| Arthralgia | 37 | 3.1% | 1 | 10 |
| Rhabdomyolysis | 35 | 2.9% | 0 | 24 |
| Fatigue | 34 | 2.8% | 0 | 11 |
Other Indications for CRESTOR
Blood cholesterol increased (640)
Blood cholesterol abnormal (73)
Hypercholesterolaemia (61)
Dyslipidaemia (32)
Hyperlipidaemia (26)
Product used for unknown indication (26)
Blood cholesterol (15)
Blood triglycerides increased (10)
Arteriosclerosis (7)
Cardiovascular event prophylaxis (7)
Other Drugs Used for Coronary artery disease
ASPIRIN (2,758)
CLOPIDOGREL BISULFATE (1,584)
EVOLOCUMAB (1,266)
ATORVASTATIN (891)
RIVAROXABAN (847)
DILTIAZEM (664)
ROSUVASTATIN (600)
TICAGRELOR (520)
QUINAPRIL (511)
AMLODIPINE (486)